OSCR

Early pharmacologic venous thromboembolism prophylaxis and in-hospital mortality in ICU patients with intracerebral hemorrhage: a landmark, propensity-weighted cohort study.

Overview

Authors: Hongfu Chen1,2, Jianyong Ji3, Hui Zhang1, Er Nie1, Qing Lan2
  1. Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
  2. Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
  3. Department of Neurosurgery, Liaocheng People’s Hospital, Liaocheng, Shandong, China
Journal: Frontiers in neurology, volume 17, article 1849021
Dates: received 7 April 2026; accepted 10 August 2026; published online 3 September 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3389/fneur.2026.1849021 · PMID 42755529 · PMCID PMC13581532 · OpenAlex W7207872445
Open access: gold, a free copy (OpenAlex)
Status: code on request (how the code is found and verified)
Categories: human (organism), stroke (population), clinical / translational (subfield)
Methods: Machine learning
Keywords: critical care, in-hospital mortality, intracerebral hemorrhage, landmark analysis, thromboprophylaxis, venous thromboembolism
MeSH: Anticoagulants*, Cerebral Hemorrhage*, Hospital Mortality*, Venous Thromboembolism*, Aged, Aged, 80 and over, Cohort Studies, Female, Humans, Intensive Care Units, Male, Middle Aged, Propensity Score, Retrospective Studies (* major topic)
Topic: Venous Thromboembolism Diagnosis and Management (Internal Medicine, Medicine), according to OpenAlex
Citations: not cited yet (Europe PMC); 27 references in the paper

Abstract

Background and purpose: The optimal timing of pharmacologic venous thromboembolism (VTE) prophylaxis in intracerebral hemorrhage (ICH) is uncertain. Using a landmark design that classifies exposure only by information available at a fixed time point, we evaluated whether initiation of pharmacologic VTE prophylaxis within 48 h of ICU admission is associated with in-hospital mortality.

Methods: Retrospective cohort study in the Medical Information Mart for Intensive Care IV (MIMIC-IV v3.1). Adults with non-traumatic ICH admitted to the ICU (2008–2019) who were alive and in hospital at a 48-h landmark were included. Exposure was fixed at the landmark: early prophylaxis = pharmacologic prophylaxis started ≤48 h; no early prophylaxis = not started by 48 h (comprising later [delayed] initiators and never-treated patients). Time zero and eligibility were ICU admission + 48 h. Inverse probability of treatment weighting (IPTW) adjusted for 17 baseline covariates including the baseline Glasgow Coma Scale (GCS). The primary outcome was in-hospital mortality (a binary outcome, with discharge alive as the competing event); the secondary outcome was coded VTE (binary). Missing GCS was handled by multiple imputation.

Results: Of 2,754 ICH ICU patients, 2,407 reached the 48-h landmark and 2,380 formed the analytic cohort (early prophylaxis, n = 655; no early prophylaxis, n = 1,725) after excluding 27 receiving therapeutic anticoagulation within 48 h. In-hospital death occurred in 371 patients (early prophylaxis 10.8%, no early prophylaxis 17.4%). After IPTW (17/17 covariates standardized mean difference <0.1), early prophylaxis was associated with lower in-hospital mortality (adjusted odds ratio [OR] 0.72, 95% confidence interval [CI] 0.55–0.94; weighted risk difference −4.0%; cause-specific hazard ratio 0.65, 95% CI 0.50–0.86, p = 0.003). There was no statistically significant difference in coded VTE (adjusted OR 1.20, 95% CI 0.85–1.69; p = 0.31). The association was directionally consistent across most sensitivity analyses—including a model that treated prophylaxis initiation as a time-varying exposure to reduce immortal-time bias (HR 0.61, 95% CI 0.49–0.76) and a competing-risk cumulative-incidence analysis—although the 24-h landmark estimate was not statistically significant.

Conclusion: In this landmark cohort, initiation of pharmacologic VTE prophylaxis within 48 h was associated with lower in-hospital mortality without a statistically significant difference in coded VTE. Because key neuroimaging severity measures (hematoma volume, location, intraventricular extension, and expansion) were unavailable, residual confounding by indication cannot be excluded and a causal interpretation is not warranted. Randomized trials are needed.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

Datasets cited

Data availability statement

Publicly available datasets were analyzed in this study. The data are available from the Medical Information Mart for Intensive Care IV (MIMIC-IV v3.1) database at https://physionet.org/content/mimiciv/3.1/. Access to MIMIC-IV requires completion of a data use agreement and human subjects research training (CITI Program). The analysis code is available from the corresponding authors upon reasonable request.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 5 authors, 6 keywords, 14 MeSH terms, 27 references.

Cite

This paper

Chen, H., Ji, J., Zhang, H., Nie, E., & Lan, Q. (2026). Early pharmacologic venous thromboembolism prophylaxis and in-hospital mortality in ICU patients with intracerebral hemorrhage: a landmark, propensity-weighted cohort study. Frontiers in neurology, 17, 1849021. https://doi.org/10.3389/fneur.2026.1849021

BibTeX

@article{chen2026early,
author = {Chen, Hongfu and Ji, Jianyong and Zhang, Hui and Nie, Er and Lan, Qing},
title = {{Early pharmacologic venous thromboembolism prophylaxis and in-hospital mortality in ICU patients with intracerebral hemorrhage: a landmark, propensity-weighted cohort study}},
journal = {Frontiers in neurology},
year = {2026},
month = sep,
volume = {17},
pages = {1849021},
publisher = {Frontiers Media SA},
issn = {1664-2295},
doi = {10.3389/fneur.2026.1849021},
url = {https://doi.org/10.3389/fneur.2026.1849021},
pmid = {42755529},
pmcid = {PMC13581532}
}

RIS

TY - JOUR
AU - Chen, Hongfu
AU - Ji, Jianyong
AU - Zhang, Hui
AU - Nie, Er
AU - Lan, Qing
TI - Early pharmacologic venous thromboembolism prophylaxis and in-hospital mortality in ICU patients with intracerebral hemorrhage: a landmark, propensity-weighted cohort study
T2 - Frontiers in neurology
J2 - Front Neurol
PY - 2026
DA - 2026/09/03
VL - 17
SP - 1849021
SN - 1664-2295
PB - Frontiers Media SA
DO - 10.3389/fneur.2026.1849021
UR - https://doi.org/10.3389/fneur.2026.1849021
LA - en
ER -

CSL-JSON

{
"id": "10.3389/fneur.2026.1849021",
"type": "article-journal",
"title": "Early pharmacologic venous thromboembolism prophylaxis and in-hospital mortality in ICU patients with intracerebral hemorrhage: a landmark, propensity-weighted cohort study",
"container-title": "Frontiers in neurology",
"author": [
{
"family": "Chen",
"given": "Hongfu"
},
{
"family": "Ji",
"given": "Jianyong"
},
{
"family": "Zhang",
"given": "Hui"
},
{
"family": "Nie",
"given": "Er"
},
{
"family": "Lan",
"given": "Qing"
}
],
"container-title-short": "Front Neurol",
"volume": "17",
"page": "1849021",
"DOI": "10.3389/fneur.2026.1849021",
"PMID": "42755529",
"PMCID": "PMC13581532",
"ISSN": "1664-2295",
"publisher": "Frontiers Media SA",
"URL": "https://doi.org/10.3389/fneur.2026.1849021",
"language": "en",
"issued": {
"date-parts": [
[
2026,
9,
3
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3389/fneur.2026.1753639
Early prophylactic heparin use is associated with reduced mortality in patients with non-traumatic subarachnoid hemorrhage.
Journal: Frontiers in neurology
In common: physionet.org/content/mimiciv, stroke, clinical / translational, 1 reference
[2] doi:10.1186/s12871-022-01822-2 [code]
Assessment of the effects of dexmedetomidine on outcomes of traumatic brain injury using propensity score analysis.
Journal: BMC anesthesiology
In common: physionet.org/content/mimiciv, clinical / translational, 1 reference
[3] doi:10.1038/s41598-026-57082-4
Glucose-to-potassium ratio has a non-linear J-shaped association with acute kidney injury risk in traumatic brain injury.
Journal: Scientific reports
In common: physionet.org/content/mimiciv, clinical / translational, 1 reference
[4] doi:10.1016/j.isci.2026.116135 [code]
Predicting ICU in-hospital mortality from text-encoded structured EHR data using adaptive transformer layer fusion.
Journal: iScience
In common: physionet.org/content/mimiciv, clinical / translational, 1 reference
[5] doi:10.1002/ibra.70015 [code]
Impact of early dexmedetomidine administration on short- and long-term outcomes in critically traumatic brain injury patients: A retrospective study using the MIMIC-IV database.
Journal: Ibrain
In common: physionet.org/content/mimiciv, clinical / translational, 1 reference
[6] doi:10.1038/s41598-025-04793-9
Latent class growth analysis of dynamic PaCo&lt;sub&gt;2&lt;/sub&gt; patterns and clinical outcomes in acute brain injury.
Journal: Scientific reports
In common: physionet.org/content/mimiciv, clinical / translational, 1 reference
[7] doi:10.3389/fmed.2025.1523535
Nomogram establishment for gastrointestinal bleeding prediction in ICU patients with traumatic brain injury based on the MIMIC-IV database.
Journal: Frontiers in medicine
In common: physionet.org/content/mimiciv, clinical / translational, 1 reference
[8] doi:10.1002/acn3.52272
Real-world efficacy of transfusion with liberal or restrictive strategy in traumatic brain injury.
Journal: Annals of clinical and translational neurology
In common: physionet.org/content/mimiciv, clinical / translational, 1 reference
[9] doi:10.1038/s43856-026-01817-x [code]
Visual prompt engineering for multimodal and irregularly sampled medical data.
Journal: Communications medicine
In common: physionet.org/content/mimiciv, clinical / translational, 1 reference
[10] doi:10.3390/bioengineering12060578 [code]
PathCare: Integrating Clinical Pathway Information to Enable Healthcare Prediction at the Neuron Level.
Journal: Bioengineering (Basel, Switzerland)
In common: physionet.org/content/mimiciv, clinical / translational, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.